103 related articles for article (PubMed ID: 17662276)
1. Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice.
Lange C; Ehlken C; Martin G; Konzok K; Moscoso Del Prado J; Hansen LL; Agostini HT
Exp Eye Res; 2007 Sep; 85(3):323-7. PubMed ID: 17662276
[TBL] [Abstract][Full Text] [Related]
2. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
[TBL] [Abstract][Full Text] [Related]
3. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
4. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Fang X; Ueno M; Yamashita T; Ikuno Y
Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
[TBL] [Abstract][Full Text] [Related]
5. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
[TBL] [Abstract][Full Text] [Related]
6. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
7. Squalamine improves retinal neovascularization.
Higgins RD; Sanders RJ; Yan Y; Zasloff M; Williams JI
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1507-12. PubMed ID: 10798670
[TBL] [Abstract][Full Text] [Related]
8. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analogs inhibit neonatal retinal neovascularization.
Higgins RD; Yan Y; Schrier BK
Exp Eye Res; 2002 May; 74(5):553-9. PubMed ID: 12076076
[TBL] [Abstract][Full Text] [Related]
10. The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization.
Kataoka K; Nishiguchi KM; Kaneko H; van Rooijen N; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1431-8. PubMed ID: 21051720
[TBL] [Abstract][Full Text] [Related]
11. Retinal vascular rescue of oxygen-induced retinopathy in mice by norrin.
Tokunaga CC; Chen YH; Dailey W; Cheng M; Drenser KA
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):222-9. PubMed ID: 23188723
[TBL] [Abstract][Full Text] [Related]
12. New quantitative analysis, using high-resolution images, of oxygen-induced retinal neovascularization in mice.
Chikaraishi Y; Shimazawa M; Hara H
Exp Eye Res; 2007 Mar; 84(3):529-36. PubMed ID: 17208227
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin inhibits the retinal neovascularization in vitro and in vivo.
Chikaraishi Y; Matsunaga N; Shimazawa M; Hara H
Exp Eye Res; 2008 Jan; 86(1):131-7. PubMed ID: 18031740
[TBL] [Abstract][Full Text] [Related]
14. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.
Maier P; Unsoeld AS; Junker B; Martin G; Drevs J; Hansen LL; Agostini HT
Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):593-600. PubMed ID: 15650859
[TBL] [Abstract][Full Text] [Related]
16. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effects of FK228 on retinal neovascularization].
Li L; Peng YL; Lü K
Zhonghua Yan Ke Za Zhi; 2007 Feb; 43(2):142-5. PubMed ID: 17459245
[TBL] [Abstract][Full Text] [Related]
18. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
[TBL] [Abstract][Full Text] [Related]
19. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Priel A; Rosner M; Pri-Chen S; Spierer A
Curr Eye Res; 2012 Jul; 37(7):624-9. PubMed ID: 22578253
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.
Higgins RD; Yu K; Sanders RJ; Nandgaonkar BN; Rotschild T; Rifkin DB
Curr Eye Res; 1999 Jan; 18(1):20-7. PubMed ID: 10075199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
